Who should receive myeloablative therapy for lymphoma?

N Engl J Med. 2004 Mar 25;350(13):1277-8. doi: 10.1056/NEJMp048007.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Combined Modality Therapy
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Humans
  • Lymphoma / therapy*
  • Prednisone / administration & dosage
  • Stem Cell Transplantation*
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol